摘要
目的:研究肾舒康合剂对马杉氏肾炎(MGN)白兔肾组织形态学的影响。方法:经白兔耳缘静脉注射羊抗兔肾血清以复制白兔MGN模型。实验分为4组,即正常(等容量生理盐水)、模型(等容量生理盐水)、雷公藤多苷(5mg·kg-1)和肾舒康合剂(8.16g·kg-1)组。复制模型后第1天开始ig给药,并于给药4周末杀检动物,取肾组织行光镜、电镜检查并进行半定量分析。结果:肾舒康能减轻肾小球系膜增生和炎性细胞浸润,改善肾小球的病理损伤状况。结论:肾舒康能通过改善肾组织病理改变,达到防治肾小球硬化的作用。
OBJECTIVE: To study the effect of Shenshukang(SSK)mixture on histomorphology of rabbits with masugi glomerulone phritis(MGN). METHODS:MGN model was induced by sheep antirabbits serum on ear vein. Model rabbits were divided into 4 groups, including normal group(equal volume of normal saline), model group(equal volume of normal saline), tripterygium glyco- sides group (5 mg.kg-1)and SSK(8.16 g,kg-1) group. Those groups were treated with relevant medicines intragastrically. After 4 weeks, the animals were sacrificed and nephridial tissue was observed with optical microscope and transmission electron microscope, at the same time, the semi-definite quantity analysis was carries out. RESULTS: SSK can relieve the hyperplasy of glomerular mesangium and inflammatory cell infiltrate, amendment pathologic changes of glomcrulus. CONCLUSIONS: Shenshukang can improve histomorphology and prevent glomerulus sclerosis.
出处
《中国药房》
CAS
CSCD
北大核心
2011年第47期4422-4424,共3页
China Pharmacy
基金
河北省中医药管理局中医药
中西医结合科研计划课题(2009101)
关键词
肾舒康
马杉氏肾炎
病理学
Shenshukang
Masugi glomerulone phritis
Pathology